Botanical species · safety record

Premna serratifolia

The EFSA Compendium of Botanicals holds 8 constituent measurements for Premna serratifolia. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Premna serratifolia L.

8Constituent measurements
0Safety records
6Cited sources
0Licensed products (Canada)

Also recorded as

Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

  • Alkaloids3
  • Tannins2
  • 4-hydroxybenzaldehyde1
  • Cardiac glycosides1
  • Lignans1

Plant parts

  • Roots and other underground parts4
  • Leaves3
  • Stem1
  • stalk1

Preparations

  • Solvent extraction8

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
AlkaloidsStem / stalkSolvent extractionPhytochemical screeningResolve DOI
4-hydroxybenzaldehydeLeavesSolvent extractionStandard Chromatographic tests (paper- thin layer- and column chromatography)No resolvable identifier
AlkaloidsLeavesSolvent extractionPhytochemical screeningNo resolvable identifier
AlkaloidsRoots and other underground partsSolvent extractionPhytochemical screeningNo resolvable identifier
Cardiac glycosidesRoots and other underground partsSolvent extractionGelpermeation, High Performance Thin Layer Chromatography (HPTLC)No resolvable identifier
LignansRoots and other underground partsSolvent extraction0.073 PercentHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)No resolvable identifier
TanninsRoots and other underground partsSolvent extractionPhytochemical screeningNo resolvable identifier
TanninsLeavesSolvent extractionPhytochemical screeningNo resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Mali, Prashant Y., Bhadane, Vijay V. Comparative account of screening of bioactive ingredients of Premna integrifolia Linn. with special reference to root by using various solvents. Journal of pharmacy research, 2010, vol. 3, no. 7, p. 1677-1679.
  2. Rajendran, Rekha., Suseela, L., Sundaram, Meenakshi R., Basha, Saleem N. Cardiac stimulant activity of bark and wood of Premna serratifolia. Bangladesh journal of pharmacology, 2008, vol. 3, no. 2, p. 107-113. DOI
  3. Gokani, Rina H., Kapadia, Nayana S., Shah, Mamta B. Comparative pharmacognostic study of Clerodendrum phlomidis and Premna integrifolia . Journal of natural remedies, 2008, vol. 8, no. 2, p. 222-231.
  4. Nguyen Thi Bich Hang., Pham Thanh Ky., Chau Van Minh., Nguyen Xuan Cuong., Nguyen Phoung Thao., Phan Van Kiem. Study on the chemical constituents of Premna integrifolia L.. Natural product communications, 2008, vol. 3, no. 9, p. 1449-1452.
  5. Biradi, Mahesh., Hullatti, Kirankumar. Screening of Indian medicinal plants for cytotoxic activity by brine shrimp lethality (BSL) assay and evaluation of their total phenolic content. Drug development and therapeutics, 2014, vol. 5, no. 2, p. 139-144.
  6. Bose, Lekshmi V., George, K. V., Iyer, R. Shankar., Deepa, T. D. Identification of novel cardiac principle in the roots of Premna serratifolia L.. Journal of pharmacy research, 2012, vol. 5, no. 6, p. 3261-3264.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue